期刊文献+

泰比培南侧链合成工艺改进 被引量:2

An improved synthesis of the side chain of tebipenem
下载PDF
导出
摘要 报道了一种改进的泰比培南侧链合成方法.以苄胺和环氧氯丙烷为起始原料,经取代开环,N-烷基化反应构建四元环分子骨架,该中间体再经氢化、N-叔丁氧羰基化、O-甲烷磺酰化、取代反应、成盐等8步操作合成泰比培南侧链,总收率24.3%.与现有方法相比,反应条件温和,操作简便,试剂廉价易得. Aiming at improving the synthetic process of the side chain of tebipenem and employing benzylamine and epichlorohydrin as starting materials, a four - membered ring was constructed as the molecular framework via ring - opening substitution and N - alkylation. Subsequently, this intermediate was transformed into the side chain of tebi- penem through 8 synthetic steps, e.g. hydrogenation, N - tert - butoxycarbonylation, O - mesylation, substitution and saltification ; starting from benzylamine, the side chain of tebipenem was prepared via 10 steps with a total yield of 24.3% ; an improved method for the synthesis of the side chain of tebipenem was developed. Compared with the known methods, the new synthetic approach has the advantages of a mild reaction condition, simple operation and cheap chemical reagents, thus showing a promising prospect.
出处 《云南民族大学学报(自然科学版)》 CAS 2014年第2期85-88,共4页 Journal of Yunnan Minzu University:Natural Sciences Edition
基金 国家自然科学基金(21302163) 云南省教育厅科学研究基金(2013Z037) 云南民族大学青年基金(2012QN03)
关键词 碳青霉烯类抗生素 泰比培南侧链 合成工艺改进 carbapenem side chain of tebipenem improved synthesis
  • 相关文献

参考文献9

二级参考文献64

  • 1周贵民,张有江,张淑兰,许淑珍,张秀珍,宣天芝,陈民钧,徐英春.北京4家医院对常用较新的16种抗生素的敏感性监测[J].中华微生物学和免疫学杂志,1995,15(4):219-224. 被引量:76
  • 2黄仲义.美罗培南的药理学和临床应用[J].中国新药与临床杂志,2005,24(12):971-973. 被引量:16
  • 3Abe T,Hayashi K,Mihira A,et al.L-084,a new oral carbapenem:Synthesis and structure-activity relationships of C2substituted 1beta-methylcarbapenems.38th Intersci Conf Antimicrob Agents Chemother (ICAAC),(Sept 24-27,San Diego),1998,Abst F-64.
  • 4Isoda T,Sato C,Mihira A,et al.(Wyeth-Lederle Japan,Ltd.).2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thiocarbapenem derivatives.EP 0632039,EP 0717042,JP 1996053453,US 5534510,US 5659043,US 5783703.
  • 5Kumagai T.(Wyeth-Lederle Japan,Ltd.).Carbapenem-3-carboxylic acid ester derivatives.EP 0808315,JP 1999504039,US 5886172,WO 9721712.
  • 6Yasuda S,Okue M,Hori N.(Meiji Seika Kaisha,Ltd).Process for producing carbapenem derivative and intermediate for use in the production.WO 2004035539.
  • 7Nishino K,Koga T.(Kaneka Corporation).Process for producing carbapenem compound for oral administration.EP 1580191.
  • 8西野敬太,古贺照义.经口给药用碳青霉素烯化合物的新的合成中间体及其制造方法.CN1708504A.
  • 9Kato N,Kato H,Tanaka K,Watanabe K.L-084,a new oral carbapenem:In vitro activity against anaerobic bacteria.38th Intersci Conf Antimicrob Agents Chemother (ICAAC) (Sept 24-27,San Diego),1998,Abst F-70.
  • 10Kobayashi R,Konomi N,Hasegawa K,et al.In vitro antivity of tebipenem,a new oral carbapenem antibiotic,against penicillin-nonsusceptible Streptococcus pneumonia.Antimicrob Agents Chemother,2005,49:889-894.

共引文献42

同被引文献14

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部